DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL recall — FDA D-0345-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
Recall history in this database
Classification mix: Class II: 15.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL recall — FDA D-0343-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL recall — FDA D-0340-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL recall — FDA D-0344-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL recall — FDA D-0339-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL recall — FDA D-0334-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL recall — FDA D-0342-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL recall — FDA D-0336-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL recall — FDA D-0333-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL recall — FDA D-0341-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL recall — FDA D-0332-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL recall — FDA D-0331-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL recall — FDA D-0337-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL recall — FDA D-0338-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
DrugMar 1, 2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL recall — FDA D-0335-2023
Subpotent Drug
Class IIFDA: TerminatedIBSA PHARMA Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies IBSA PHARMA Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.